Richard C Ahrens MD
Professor of Pediatrics, University Iowa College of Medicine
Join to View Full Profile
200 Hawkins DrIowa City, IA 52242
Phone+1 319-356-1828
Fax+1 319-356-7171
Dr. Ahrens is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Allergy and Immunology, 1977 - 1980
SSM Health/Saint Louis University School of MedicineResidency, Pediatrics, 1974 - 1975- SSM Health/Saint Louis University School of MedicineInternship, Internal Medicine, 1973 - 1974
Medical College of WisconsinClass of 1973
Certifications & Licensure
IA State Medical License 1977 - 2021
AR State Medical License 1973 - 2019
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics
Clinical Trials
- OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis Start of enrollment: 2014 Jun 01
- Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation Start of enrollment: 2015 Nov 01
Publications & Presentations
PubMed
- 1 citationsA Dose-Response Study Examining the Use of Methacholine Challenge to Demonstrate Local Therapeutic Equivalence of the Salmeterol Component of Generic Inhaled Fluticaso...Richard Allan, Scott Haughie, Richard C. Ahrens, Sachinkumar B. Singh, Jon Ward
Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2019-12-05 - 1 citationsEffect of Study Design on Sample Size in Studies Intended to Evaluate Bioequivalence of Inhaled Short-Acting β-Agonist FormulationsYaohui Zeng, Sachinkumar B. Singh, Kai Wang, Richard C. Ahrens
Journal of Clinical Pharmacology. 2018-04-01 - 164 citationsAirway microbiota across age and disease spectrum in cystic fibrosisEdith T. Zemanick, Brandie D. Wagner, Charles E. Robertson, Richard C. Ahrens, James F. Chmiel
The European Respiratory Journal. 2017-11-01
Grant Support
- Ultrase MT20 For Correction Of Steatorrhea In Patients With Cystic FibrosisNational Center For Research Resources2007
- Tiotropium Bromide Administered VIA The Respimat Device In CF PatientsNational Center For Research Resources2007
- Genetic Modifiers Of Cystic Fibrosis: Sibling StudyNational Center For Research Resources2007
- Eurand Pancreatic Enzyme Product Microtabs In Pediatric CF PatientsNational Center For Research Resources2007
- Eruand Pancreatic Enzyme Product (PEP) In Patients With Cystic FibrosisNational Center For Research Resources2007
- Aztreonam Lysinate In CF Patients With Pulmonary Pneumonia AeruginosaNational Center For Research Resources2007
- Antimicrobial Therapy For New Onset Pseudomonas Aeruginosa Airway InfectionNational Center For Research Resources2006–2007
- Standard Versus Biofilm Susceptibility Testing In Cystic FibrosisNational Center For Research Resources2005–2007
- Multicenter Investigation Of Genetic Modifier In CF Lung Or Liver Disease StudyNational Center For Research Resources2005–2007
- Induced Sputum To Evaluate Anti-Inflammatory Agents In CF PatientsNational Center For Research Resources2006
- Oral Theraclec-Total In Cystic Fibrosis SubjectsNational Center For Research Resources2005
- Biil 284 Bs In Adult And Pediatric Cystic Fibrosis PatientsNational Center For Research Resources2005
- Oral Theraclec To Treat Cystic FibrosisNational Center For Research Resources2004
- Biil 284 Bs In Adult And Pediatric Cystic FibrosisNational Center For Research Resources2004
- Aztreonam For Inhalation In Subjects W/ Cystic FibrosisNational Center For Research Resources2004
- Trial Of Ib-367 In Adult Patients With Cystic FibrosisNational Center For Research Resources2000–2002
- Elastase In BAL Fluid W Tg-Haat Treated Cystic FibrosisNational Center For Research Resources2000–2002
- Oral Multidose CPX In Adult Patients W/ Cystic FibrosisNational Center For Research Resources1999–2002
- Phase I Trial Of CPX In Adults With Mild Cystic FibrosisNational Center For Research Resources1998–2000
- Albuterol By DRY Powder Inhaler &Pressurized Metered Dose Ventolin InhalerNational Center For Research Resources1998–2000
- Dose Response Curve For Beclomethasone Dipropionate In AsthmaNational Center For Research Resources1996–1997
- Bronchoprovocation With Histamine For Bioequivalence Determination Of AlbuterolNational Center For Research Resources1996–1997
- Clinical Parameters For Establishing Dose Response Curves For CorticosteroidsNational Center For Research Resources1996
- Glucocorticoids To Treat Bronchopulmonary DysplasiaNational Center For Research Resources1992–1996
- The Albuterol Dose-Fev1 Response Curve In Subjects With AsthmaNational Center For Research Resources1992–1993
- Pharmacokinetic Evaluation Of A Slow Release Theophylline Tablet In ChildrenNational Center For Research Resources1992–1993
- Comparison Of Beta-2 Agonists Using Bronchial Provocation With HistamineNational Center For Research Resources1992–1993
- Tolerance To Inhaled BETA2 AgonistsNational Center For Research Resources1992
- The Effect Of Inhaled Nedocromil On Airway Response To Inhaled AlbuterolNational Center For Research Resources1992
- Effects Of Nedocromil On Airway Response To Inhaled AlbuterolNational Center For Research Resources1992
- Effects Of Oral Azelastine On Airway Responisvieness To HistamineNational Center For Research Resources1990
- Effects Of Inhaled Fluticasone Proprionate Versus Placebo In Adult AsthmaticsNational Center For Research Resources1990
- Comparison Of Beta-2 Agonists Using Bronchial Provocation With Histamine (HumanNational Center For Research Resources1990
- Mechanism Of Histamine Induced BronchospasmNational Center For Research Resources1985
- Development Of Tolerance For MetaproterenolNational Center For Research Resources1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
